Siteman Advantage

Fact: The Siteman Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center in Missouri and is ranked among the top cancer facilities in the nation by U.S. News & World Report.

What this means for you: They provide a full range of cancer diagnosis and treatment options led by specialists at the top of their field, many involved in leading-edge research on novel therapies.

Fact: The Siteman Cancer Center sees 120 new patients with MDS per year.

What this means for you: You will get a high level of care from experts skilled at treating MDS. The average general practitioner sees only one to two cases of MDS each year. Even blood specialists may only see 10 cases per year at most. This means that MDS may be under-recognized by doctors who are not as familiar with it. At Siteman, your doctors will be able to provide you with an accurate diagnosis and a treatment plan that is designed for you and your condition.

Fact: Siteman Cancer Center is located at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.

What this means for you: Your doctors are academic researchers who study the conditions they treat. They will have a superior understanding of your illness and how to treat it. Patients also have the opportunity to participate in research by donating tissue samples from their regular exams and lab work. In doing so, they provide critical assistance to doctors and scientists working to advance medical knowledge, helping other patients in the future.

Fact: Siteman has one of the largest-volume bone marrow/stem cell transplant programs in the world, performing about 400 transplants a year.

What this means for you: During your in-patient stay, you will be housed in a protected space dedicated to transplants, with HEPA filtering systems to prevent infections while your immune system is compromised. The facilities, including the recently-opened Parkview Tower, are state-of-the-art and tailored to transplant patients’ needs. You will be cared for by physicians who have extensive experience performing transplants, and by nurses who are specialists in transplant patient care.

Fact: Siteman pioneered the development of genomic testing for precision cancer treatment. This allows doctors to target therapies to the genetic components of the cancer.

What this means for you: Knowing the genetic makeup of your myelodysplastic syndrome yields important information about which treatments may be more effective and what your prognosis might be. Patients with MDS and other blood cancers will have their genes sequenced with Myeloseq, a new sequencing tool designed here at Siteman Cancer Center.

Fact: Siteman has the most clinical trials in the region. Frequently, a promising trial is recommended as a first-line treatment.

What this means for you: The standard of care at a research hospital is often clinical trials, meaning you get treatments not otherwise available. These new drugs and therapies can offer excellent results, and allow patients to benefit from some of the most recent breakthroughs in cancer science.